Supplementary Methods

Determination of repeat CTG triplet size
The repeat CTG triplet size was analyzed by both southern blot and PCR as described previously (Cleary et al., 2010; Gomes-Pereira et al., 2007) .
Analysis of the NMDAR1 splice
NMDAR1 splice defects were detected and quantified by real-time PCR performed with on an ABI Prism 7900HT (Applied Biosystems). The primer and the probes used for detection were: NMDAR1 ex.5 sense: 5'-CGACCAACTGTCCTATGACAACA-3', probe: 5'-CGCGGACCCAAGG-3', antisense: 5'-GGTCAAACTGCAGCACCTTCT-3', NMDAR1 total sense: 5'-TGGAGGAGCGTGAGTCCAA-3', probe: 5'-CAGAGAAGGTGCTGCAG-3', antisense: 5'-AGGGCCGTCACGTTCTTG-3'.
Cholinergic Differentiation and co-culture with muscle cells
Human ES cells were seeded on quiescent murine bone marrow-derived stromal feeder cells MS5 at 1 x 10 3 cells / cm 2 in DMEM / F12 medium supplemented with 15% knockout serum replacement, 1 mM nonessential amino acids, and 0.55 mM 2-mercaptoethanol and 1%
penicillin/streptomycin (all from Invitrogen). After 16 days, medium was switched to N2 medium composed of DMEM / F12 supplemented with insulin (25 ng/ml), transferrin (50 ng/ml), putrescine (100 M), selenium chloride (30 nM), and progesterone (20 nM) (all from Sigma-Aldrich) and the growth factors Sonic Hedgehog (Shh) (300 ng/ml), BDNF (20 ng/ml) (R & D Systems), retinoic acid (RA) (30 ng/ml) and laminin (Sigma-Aldrich). After 24 days of differentiation, neural rosettes were mechanically harvested and plated on poly-ornithine / laminin-coated culture dishes (passage 1). After 10 days, cholinergic precursors were exposed to collagenase (100 ng/ml) for 15 minutes at 37°C, and plated onto poly-ornithine / laminin-coated culture dishes in the presence of Shh (30 ng/ml), BDNF (20 ng/ml), RA (3 ng/ml) and laminin (passage 2). One week later, inductive signals were withdrawn and replaced by 20 ng/ml BDNF, 20 ng/ml GDNF, 10 ng/ml CNTF,10 ng/ml NT-3 and 200 mM ascorbic acid.
The medium was changed every 2-3 days throughout this process.
For the co-culture with muscle cells, neuronal cells were harvested at 25 days, seeded on differentiated human Mu2bR3 cells (gift of Bioalternatives®) and maintained in a neural and muscular medium mix as previously described (Braun et al., 1996) .
Immunocytochemistry and in situ hybridization
The following primary antibodies were used : rabbit anti Neuronal Class III β-tubulin (TujI) (Covance, 1/500), rabbit anti Microtubule Associated Protein 2 (MAP2) (Covance, 1/500), mouse anti Islet-1 (Isl-1) (DSHB, 1/100), mouse anti Hb9 (DSHB, 1/100), guinea pig anti Vesicular Acetylcholine Transporter VAChT (Millipore, 1/500), mouse anti Mbnl1 (3A4) (Santa Cruz biotechnology, 1/100), Alexa 488 α-bungarotoxin (α-BTX) (Invitrogen, 1/500).
Plasmids
SLITRK2 cDNA was obtained by using a SLITRK2 antisense primer: 5'-CCAACAGTTCGGAGCAGCATC-3' during the reverse transcription of wild type MSC RNA. Then, the CDS of SLITRK2 was amplified by PCR using the primers listed in supplementary table 1. The CDS of SLITRK4 was amplified by PCR from the Imagenes-bio cDNA Clone Sequencing HU4_p940D12182D using the primers listed in supplementary table 1. PCR products were cloned using the "Zero blunt TOPO PCR cloning kit" (Invitrogen).
Insertion into the pcDNA3 plasmid was performed using BamHI / EcoRV restriction sites.
The insert was purified using "NucleoSpin Extract II" kit (Macherey-Nagel) and ligation 
